Evidence map›Paper›PMID 38566234›Full record

ArticleMolecular brain2024

Synaptopodin is required for long-term depression at Schaffer collateral-CA1 synapses.

Yanis Inglebert, Pei You Wu, Julia Tourbina-Kolomiets, Cong Loc Dang, R Anne McKinney

Open access · goldAbstract read
In one paragraph

Article in Molecular brain, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
  3. Synaptopodin: a key regulator of Hebbian plasticity.Frontiers in cellular neuroscience · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Yanis InglebertDepartment of Pharmacology and Therapeutics, McGill University, Montreal, Canada. yanis.inglebert@umontreal.ca.ORCID 0009-0002-7027-2450
Pei You WuDepartment of Pharmacology and Therapeutics, McGill University, Montreal, Canada.
Julia Tourbina-KolomietsDepartment of Pharmacology and Therapeutics, McGill University, Montreal, Canada.
Cong Loc DangDepartment of Pharmacology and Therapeutics, McGill University, Montreal, Canada.
R Anne McKinneyDepartment of Pharmacology and Therapeutics, McGill University, Montreal, Canada. anne.mckinney@mcgill.ca.
McGill University · CAUniversité du Québec · CA

Funding

CIHR MOP 86724
6 · The paper itself

Abstract

Synaptopodin (SP), an actin-associated protein found in telencephalic neurons, affects activity-dependant synaptic plasticity and dynamic changes of dendritic spines. While being required for long-term depression (LTD) mediated by metabotropic glutamate receptor (mGluR-LTD), little is known about its role in other forms of LTD induced by low frequency stimulation (LFS-LTD) or spike-timing dependent plasticity (STDP). Using electrophysiology in ex vivo hippocampal slices from SP-deficient mice (SPKO), we show that absence of SP is associated with a deficit of LTD at Sc-CA1 synapses induced by LFS-LTD and STDP. As LTD is known to require AMPA- receptors internalization and IP3-receptors calcium signaling, we tested by western blotting and immunochemistry if there were changes in their expression which we found to be reduced. While we were not able to induce LTD, long-term potentiation (LTP), albeit diminished in SPKO, can be recovered by using a stronger stimulation protocol. In SPKO we found no differences in NMDAR, which are the primary site of calcium signalling to induce LTP. Our study shows, for the first time, the key role of the requirement of SP to allow induction of activity-dependant LTD at Sc-CA1 synapses.

Indexed as

DepressionSchaffer CollateralsAnimalsHippocampusLong-Term PotentiationLong-Term Synaptic DepressionMiceMicrofilament ProteinsNeuronal PlasticitySynapsesMicrofilament ProteinsSynpo protein, mousehippocampusIP3LTDSTDPSynaptic plasticitySynaptopodin

Identifiers

PMID38566234
PMCPMC10988887
OpenAlexW4393408423

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.